Dihexa is a synthetic hexapeptide derived from angiotensin IV that has attracted significant scientific interest for its potent activity at the hepatocyte growth factor (HGF)/c-Met signaling axis. Originally developed through Washington State University research, dihexa has been investigated in preclinical models for its effects on synaptogenesis, dendritic spine density, and cognitive biology — making it one of the most studied neuropeptides in contemporary laboratory research. Studies have investigated dihexa at concentrations orders of magnitude more potent than brain-derived neurotrophic factor (BDNF) in certain assays, positioning it as a highly compelling subject for neuroscience researchers.

This guide provides a structured overview of what the current literature reveals about dihexa’s mechanisms, the biological pathways it engages, and how research laboratories approach its study. For researchers seeking the definitive deep-dive, the Dihexa: The Definitive Research Guide serves as the authoritative pillar resource in this series — it is recommended reading for anyone building a serious understanding of this compound’s research landscape.

Research-only notice: This content is provided for educational discussion and laboratory research purposes only. No medical claims are made or implied.

🎫 First order? Save 25% with code WELCOMEHOME at checkout

Research compounds discussed in this guide

Dihexa — 10MG

Dihexa - 10MG — Research-Grade Reference Material Dihexa - 10MG is supplied as a lyophilized powder for in-vitro laboratory research use only. SourcePeptides supplies this material strictly as a laboratory reference standard.…

$90.00 ($67.50 With Your 1st Order)

View Research Data →

Related compounds

Pfizer Hospira Bacteriostatic Water – 30 mL $45.00$33.75 with 1st order Dihexa - 10MG - Nasal Spray $100.00$75.00 with 1st order Selank - 10MG $45.00$33.75 with 1st order KLOW (GHK-CU, BPC-157, TB-500 & KPV) 80MG $105.00$78.75 with 1st order

For research use only · 3rd-party tested · Free 2-5 day US shipping

Frequently Asked Questions

What is dihexa?

Dihexa is a synthetic hexapeptide analog derived from angiotensin IV. It has been studied in preclinical models for its ability to potentiate HGF/c-Met receptor signaling, a pathway associated with synaptogenesis and dendritic spine formation in animal research. It is available exclusively for laboratory and research purposes.

How does dihexa work at the molecular level?

Research suggests dihexa acts as a potentiator of the hepatocyte growth factor (HGF) / c-Met signaling pathway. Studies have demonstrated that it binds HGF with high affinity, facilitating receptor dimerization and downstream signaling cascades that support synaptic density in animal models. It does not directly bind the c-Met receptor itself but works by enhancing HGF’s ability to engage it.

What does dihexa research focus on?

The majority of peer-reviewed dihexa research has explored its effects on cognitive function in animal models, particularly memory and learning tasks. Studies have also investigated its role in promoting dendritic spine outgrowth, neural connectivity, and hippocampal synaptogenesis in rodent models of cognitive decline.

What is the difference between dihexa and BDNF?

BDNF (brain-derived neurotrophic factor) acts on TrkB receptors to support neuronal survival and plasticity. Dihexa operates through the separate HGF/c-Met axis. Preclinical research has suggested dihexa may potentiate synaptogenesis at significantly lower concentrations than BDNF in certain in vitro assays, though these are distinct mechanisms and direct comparisons remain an active area of study.

Is dihexa the same as P21 or Adamax?

No. Dihexa, P21, and Adamax are distinct research peptides with different structures and mechanisms. Dihexa targets the HGF/c-Met axis. Adamax has been investigated for BDNF pathway modulation. P21 is a CNTF-derived peptide studied for hippocampal neurogenesis. Researchers may study them individually for their unique mechanistic profiles.

What research models have been used to study dihexa?

Dihexa has been studied primarily in rodent models, including rats and mice subjected to scopolamine-induced cognitive impairment, aged animal models, and surgical models of brain injury. In vitro hippocampal cell culture studies have also been used to examine its effects on dendritic spine density and synaptogenesis.

Where can researchers source dihexa for laboratory study?

Dihexa is available as a lyophilized peptide and in nasal spray formulation from qualified research peptide suppliers. It is intended strictly for laboratory and preclinical research applications, not for human consumption.

Dihexa’s Origins: From Angiotensin IV to Synthetic Hexapeptide

Dihexa’s molecular origins trace back to the angiotensin family of peptides. Angiotensin IV is a naturally occurring fragment of the renin-angiotensin system, and researchers discovered that certain structural modifications to this fragment could yield potent neuroprotective activity. The resulting compound — dihexa, chemically designated as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide — is a lipophilic, metabolically stable peptide designed to resist rapid enzymatic degradation, a common limitation of native angiotensin fragments.

🎫 First order? Save 25% with code WELCOMEHOME at checkout

Research compounds discussed in this guide

Dihexa — 10MG

Dihexa - 10MG — Research-Grade Reference Material Dihexa - 10MG is supplied as a lyophilized powder for in-vitro laboratory research use only. SourcePeptides supplies this material strictly as a laboratory reference standard.…

$90.00 ($67.50 With Your 1st Order)

View Research Data →

Related compounds

Pfizer Hospira Bacteriostatic Water – 30 mL $45.00$33.75 with 1st order Dihexa - 10MG - Nasal Spray $100.00$75.00 with 1st order Selank - 10MG $45.00$33.75 with 1st order KLOW (GHK-CU, BPC-157, TB-500 & KPV) 80MG $105.00$78.75 with 1st order

For research use only · 3rd-party tested · Free 2-5 day US shipping

The lipophilicity of dihexa is a particularly notable structural feature studied in the research context. Studies suggest this property facilitates blood-brain barrier penetration in animal models, making it a practical subject for in vivo cognitive research. Researchers interested in the full structural and molecular architecture analysis of this compound will find significant detail in the complete researcher’s overview of dihexa as a synthetic hexapeptide, which covers the chemical design rationale in depth.

The HGF/c-Met Signaling Pathway: Dihexa’s Primary Research Target

The hepatocyte growth factor (HGF) and its receptor c-Met represent one of the most extensively studied receptor tyrosine kinase systems in neurobiology. While originally characterized in the context of liver regeneration and tissue repair, subsequent research has revealed that HGF/c-Met signaling plays a critical role in neuronal survival, axonal guidance, synaptogenesis, and long-term potentiation (LTP) — all processes relevant to learning and memory biology.

How Research Models Describe Dihexa’s HGF Interaction

Dihexa is not a direct receptor agonist. Instead, studies have characterized it as an HGF potentiator — a molecule that enhances the binding of endogenous HGF to the c-Met receptor. Surface plasmon resonance experiments have demonstrated that dihexa binds to HGF with high affinity (Kd in the low nanomolar range), and this interaction is thought to promote the HGF dimerization necessary for full c-Met receptor activation. Once the receptor is activated, downstream signaling cascades including PI3K/Akt and MAPK/ERK pathways are engaged, supporting cellular processes linked to synaptic plasticity.

Synaptogenesis and Dendritic Spine Research

One of the most frequently cited areas of dihexa research concerns its effects on dendritic spine density. Dendritic spines are the postsynaptic structures that receive synaptic input; their density and morphology are closely associated with cognitive function in animal models. Preclinical studies have reported that dihexa treatment in rodents was associated with increased dendritic spine density in hippocampal neurons compared to controls — a finding that has generated substantial interest in neuroscience research communities. For a detailed breakdown of these mechanisms alongside the full HGF/c-Met signaling biology, the Dihexa research overview covering mechanisms and cognitive biology studies (2026) is a recommended resource.

Dihexa – 10MG (lyophilized) for research →

Cognitive Biology Studies: What Animal Research Has Shown

The cognitive biology associated with dihexa has been examined through multiple preclinical paradigms. Rodent models have included Morris Water Maze tasks (spatial navigation and memory), novel object recognition tests, and radial arm maze assessments — all standard tools for evaluating hippocampus-dependent learning in preclinical research.

Scopolamine-Induced Impairment Models

A commonly employed experimental design involves administering scopolamine — a muscarinic acetylcholine receptor antagonist — to temporarily impair cholinergic neurotransmission and induce a state resembling cognitive dysfunction in rodents. Studies using this model have reported that dihexa-treated animals showed measurable improvements in task performance compared to scopolamine-only controls, suggesting that HGF/c-Met pathway engagement may interact with cholinergic circuits relevant to memory formation.

Aged Animal Models

Research has also explored dihexa in aged rodent models, where age-associated decline in synaptic density and cognitive performance provides a relevant experimental context. Findings from these models have suggested that HGF potentiation via dihexa may be associated with partial restoration of dendritic spine density and improved performance on spatial memory tasks. These results remain in the preclinical domain and have not been extrapolated to clinical conclusions. Researchers studying other neuropeptides in the cognitive biology space may also find it useful to compare with a ranked comparison of dihexa, Adamax, and Semax cognitive peptide research for contextual positioning of each compound’s mechanistic profile.

Dihexa vs. Other Neuropeptides in Research Contexts

Understanding dihexa in isolation is informative, but researchers often benefit from understanding how it compares to related compounds in terms of mechanism and research focus.

Researchers interested in Adamax peptide research and its BDNF signaling mechanisms will find the mechanistic contrast with dihexa’s HGF-axis activity particularly instructive when designing multi-arm preclinical studies.

Choose Dihexa if…

• The research focus is specifically on HGF/c-Met receptor biology
• The experimental model involves synaptogenesis or dendritic spine morphology
• The laboratory is studying hippocampus-dependent learning tasks in rodents
• The study design requires a lipophilic, metabolically stable peptide with demonstrated blood-brain barrier penetration in animal models

Consider Alternatives if…

• The research focus is on BDNF/TrkB signaling pathways (consider Adamax)
• The study involves acute neuroprotection or ischemia models (consider Semax or BPC-157 in relevant paradigms)
• The experimental design requires compounds with more extensive Phase I/II human pharmacokinetic data available in the public literature

Dihexa – 10MG Nasal Spray for research →

Laboratory Handling and Research Formulation Considerations

Dihexa is available to researchers in two primary formats: lyophilized powder and nasal spray formulation. Each has distinct practical implications for laboratory work.

Lyophilized Dihexa

Lyophilized dihexa offers flexibility in reconstitution, allowing researchers to prepare solutions of variable concentration suited to their experimental design. When working with lyophilized research peptides, proper reconstitution using bacteriostatic water and storage protocols are critical for maintaining peptide integrity. Researchers new to working with lyophilized compounds may benefit from reviewing the complete guide to what the lyophilized powder form means for peptide research, which covers reconstitution, storage, and stability considerations in detail.

Nasal Spray Formulation

Nasal spray dihexa is prepared as a ready-to-use intranasal delivery format. This format has been employed in rodent intranasal administration studies that seek to model olfactory-to-brain delivery routes — a pathway of interest given dihexa’s CNS research focus. The nasal formulation removes reconstitution variables and provides a consistent delivery vehicle for standardized preclinical protocols.

Adamax – 10MG for comparative cognitive research →

Related Research Compounds in the Cognitive Peptide Space

Dihexa research does not exist in isolation. Several related peptides are frequently studied alongside or in contrast to dihexa in cognitive biology research programs.

• Adamax: A BDNF-loop-derived peptide studied for synaptic plasticity via TrkB receptor pathways — mechanistically distinct from dihexa’s HGF axis activity.
• Semax: An ACTH(4-7) proline-extended analog with neuroprotective properties explored in rodent ischemia and cognitive models. Research comparing Selank and Semax provides useful context on neuropeptide research differentiation.
• Pinealon: A tripeptide studied in the context of neuroprotection and age-related cognitive biology.
• P-21: A CNTF-derived 21-amino-acid peptide studied for hippocampal neurogenesis effects in rodent models, representing a distinct neurogenic mechanism from dihexa’s synaptogenic focus.

Where Dihexa Fits in a Research Library

For researchers building a comprehensive cognitive peptide research library, dihexa occupies a unique position as the primary HGF/c-Met pathway tool compound available in the research marketplace. Its structural stability, lipophilicity, and well-characterized mechanism make it a practical and scientifically grounded choice for laboratories studying synaptic biology, memory circuitry, and neurotrophic factor signaling.

Dihexa – 10MG Lyophilized for research →

Dihexa – 10MG Nasal Spray for research →

Adamax – 10MG for comparative neuropeptide research →

Final Takeaway: Dihexa as a Research Peptide in 2026

Dihexa remains one of the most scientifically distinctive neuropeptides available for preclinical research. Its unique mechanism — potentiating endogenous HGF activity to drive c-Met receptor signaling, synaptogenesis, and dendritic spine formation — sets it apart from BDNF-pathway compounds and makes it a valuable tool for researchers investigating the molecular underpinnings of learning, memory, and synaptic architecture in animal models.

The breadth of existing literature, from in vitro hippocampal assays to in vivo rodent cognitive tasks, provides a strong scientific foundation for ongoing preclinical investigation. Researchers entering this space are encouraged to begin with the Dihexa: The Definitive Research Guide as the primary reference, supplemented by the detailed mechanistic coverage in the 2026 mechanisms and cognitive biology studies overview and the structural perspective offered in the complete researcher’s overview of dihexa as a synthetic hexapeptide. Together, these resources constitute a comprehensive cluster for serious scientific inquiry into one of the most potent synthetic neuropeptides in the current research landscape.

Sources & Further Reading

• Bhatt DL et al. — “Angiotensin IV and the AT4 receptor system” — Journal of Neurochemistry (2012)
• McCoy AT et al. — “Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents” — Journal of Pharmacology and Experimental Therapeutics (2013)
• Benoist CC et al. — “Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs” — Journal of Pharmacology and Experimental Therapeutics (2014)
• PubMed Search — Dihexa HGF c-Met Cognitive Research
• PubMed Search — Hepatocyte Growth Factor Synaptogenesis